Balık, İ. 2022. Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 . NEW ENGLAND JOURNAL OF MEDICINE , vol.386 , 1397-1408.

Balık, İ., (2022). Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 . NEW ENGLAND JOURNAL OF MEDICINE , vol.386, 1397-1408.

Balık, İSMAİL. "Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 ," NEW ENGLAND JOURNAL OF MEDICINE , vol.386, 1397-1408, 2022

Balık, İSMAİL. "Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 ." NEW ENGLAND JOURNAL OF MEDICINE , vol.386, pp.1397-1408, 2022

Balık, İ. (2022) . "Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 ." NEW ENGLAND JOURNAL OF MEDICINE , vol.386, pp.1397-1408.

@article{article, author={İSMAİL BALIK}, title={Hammond J, Leister‑Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med 2022;386:1397-408. DOI: 10.1056/NEJMoa2118542 }, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2022, pages={1397-1408} }